Insider Transactions in Q3 2022 at Taysha Gene Therapies, Inc. (TSHA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 23
2022
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,325
-1.23%
|
$9,975
$3.47 P/Share
|
|
Aug 22
2022
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
9,717
-3.48%
|
$29,151
$3.5 P/Share
|
|
Aug 19
2022
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11,482
-3.95%
|
$34,446
$3.75 P/Share
|
|
Aug 18
2022
|
Kamran Alam CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,476
-2.51%
|
$22,428
$3.87 P/Share
|
|
Jul 06
2022
|
Suyash Prasad CMO and Head of R&D |
SELL
Open market or private sale
|
Direct |
8,956
-1.66%
|
$26,868
$3.79 P/Share
|
|
Jul 05
2022
|
Suyash Prasad CMO and Head of R&D |
SELL
Open market or private sale
|
Direct |
3,905
-0.72%
|
$11,715
$3.51 P/Share
|
|
Jul 01
2022
|
Suyash Prasad CMO and Head of R&D |
SELL
Open market or private sale
|
Direct |
23,923
-4.22%
|
$71,769
$3.53 P/Share
|